Low level laser therapy versus benzydamin in prevention and treatment of oral mucositis induced by anticancer treatments (clinical and biochemical study)
DOI:
https://doi.org/10.4322/bds.2022.e3406Abstract
Objective: In this study, patients undergoing neck and head radiotherapy (RT) with or with no chemotherapy
were contrasted to the low-level laser therapy (LLLT) efficacy against benzydamine hydrochloride in treating and
preventing oral mucositis (OM) (CHT). Material and Methods: This study included 90 individuals with neck
and head cancer who were undergoing radiotherapy (RT) individually or in mixture with chemotherapy (CHT),
varying in age from 18 to 80 years. Three equal groups were randomly formulated: Group, I patients were using
oral care only, Group II patients were using benzydamine hydrochloride mouth rinse, and Group III patients
were medicated by using low-level laser therapy. The National Institute of Cancer-Common Toxicity Criteria
(NIC-CTC) and the World Health Organization (WHO) were used to rate the severity of OM, and the pain was
validated utilizing a visual analog scale (VAS). The salivary level of tumor necrotic factor-a (TNF- a) was assayed. Results: As per WHO and NIC, the grade of oral mucositis at the end of cancer treatment was less in the LLLT
group than in the other two groups. The alteration in TNF-a level was not significant. The laser group is more
liable to have less salivary levels of the pro-inflammatory cytokines TNF- a. Conclusion: The incidence of oral
mucositis severity has seemed to be reduced due to the prophylactic use of benzydamine hydrochloride and laser
therapy protocols. However, laser therapy was more efficient in controlling the shape and progression of OM.
KEYWORDS
Oral mucositis; Photobiomodulation; Radiation therapy; Chemotherapy; Low-level laser therapy; Benzydamine
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Brazilian Dental Science uses the Creative Commons (CC-BY 4.0) license, thus preserving the integrity of articles in an open access environment. The journal allows the author to retain publishing rights without restrictions.
=================
COPYRIGHT TRANSFER AND RESPONSIBILITY STATEMENT
(PDF)
For all articles published in the BDS journal, copyright is retained by the authors. Articles are licensed under an open-access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted, provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit. All metadata associated with published articles is released under the Creative Commons CC0 Universal Public Domain Dedication.
Before the submission, authors must obtain permission to reproduce any published material (figures, schemes, tables, or any extract of a text) that does not fall into the public domain or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).
The authors hereby attest that the study is original and does not present manipulated data, fraud, or plagiarism. All names listed made a significant scientific contribution to the study, are aware of the presented data, and agree with the final version of the manuscript. They assume complete responsibility for the ethical aspects of the study.
This text must be printed and signed by all authors. The scanned version should be submitted as supplemental file during the submission process.
